Merck Bovilis® Nasalgen® IP

Merck

BOVILIS^® NASALGEN^® IP

Bovine Rhinotracheitis-Parainfluenza 3 Vaccine

Product Description

The original intranasal.

Designed for convenience, the original BOVILIS^® NASALGEN^® IP vaccination is an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR) and parainfluenza 3 (PI₃) viruses.

Indications

This product has been shown effective for the vaccination of healthy cattle 5 months of age or older against infectious bovine rhinotracheitis and parainfluenza 3 viruses. Duration of immunity has not been established.

Diseases

Infectious bovine rhinotracheitis (IBR)
Parainfluenze 3 (PI₃)

Designed for no injection site reactions to help your operation meet Beef Quality Assurance standards.

Key Benefits

Fast-acting to build a strong foundation

Provides rapid onset of protection
No temperature sensitivity issues that would negatively impact replication once administered²
Stimulates active immunity in the face of maternal antibodies¹

Innovative Intranasal Delivery

Stimulates local production of antibodies at the site where infectious pathogens enter the respiratory system – the mucosal lining of the nasal cavity